2.700
+3,85%
2026-10-16
Fundamental Analysis
81 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +398.3% | +56.0% | 2 / 3 | +26.1% | +5.34 pp | +5.89 pp | -69.9% | -1.13 | 0.70 | 154 | +26,1% | 12,2 | +398,3% | 0.70 | 0.84 | −16,5% |
| Pts | 12 | 12 | 8 | 12 | 12 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 2.700 (close price on 2026-10-16)EPS (TTM): 3.851
Financial charts
1.Revenue & growth
VND bn154Q2/26
1.Revenue & growth
VND bn154Q2/26
2.Profit & growth
VND bn12,2Q2/26
3.Profit mix (Penman)
VND bn292Q2/26
4.Margins & cost structure
%6.5%Q2/26
5.Returns & cash cycle
% · days-62.1%Q2/26
6.Earnings quality & cash
VND bn119Q2/26
7.Asset structure
VND bn632Q2/26
8.Funding & debt health
VND bn · times632Q2/26
9.Revenue backlog
VND bn41,3Q2/26
10.Valuation
times · %0,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %177Q2/26
Adjusted EPS growth, latest quarter
398%
Average adjusted EPS growth, 3 quarters
56.0%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26